AI-Designed Candidate

About AbSci

Absci's mission is to create better biologics for patients, faster by overcoming traditional drug discovery bottlenecks. The company has evolved from its synthetic biology roots into an integrated AI biotech, building a proprietary data 'moat' and a closed-loop platform that designs and validates drug candidates in iterative six-week cycles. Its strategy leverages this platform to advance an internal pipeline and forge strategic partnerships, positioning it at the forefront of AI-driven therapeutic design.

Therapeutic Areas